Local view for "http://liddi.stanford.edu/LIDDI:SID3421"

PredicateValue (sorted: none)
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and dapsone - Event - Neutropenia. [LIDDI_resource:SID3421_SID0372_EID4963]110
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and vincristine - Event - Pancytopenia. [LIDDI_resource:SID3421_SID1388_EID4962]146
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and flecainide - Event - Arrhythmia. [LIDDI_resource:SID3421_SID0542_EID4966]115
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and ramipril - Event - Pancytopenia. [LIDDI_resource:SID3421_SID2129_EID4962]164
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and morphine - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0869_EID4971]135
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between estradiol and valganciclovir - Event - Arrhythmia. [LIDDI_resource:SID0491_SID3421_EID4966]19
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between nystatin and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID0930_SID3421_EID4970]43
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and etomidate - Event - Arrhythmia. [LIDDI_resource:SID3421_SID0516_EID4966]113
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between cefuroxime and valganciclovir - Event - Arrhythmia. [LIDDI_resource:SID0253_SID3421_EID4966]11
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between etomidate and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID0516_SID3421_EID4970]22
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ramipril and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID2129_SID3421_EID4965]67
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between letrozole and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID2630_SID3421_EID4970]91
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and warfarin - Event - Parkinsonism. [LIDDI_resource:SID3421_SID1397_EID4965]148
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and naproxen - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0886_EID4962]138
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and megestrol - Event - Bradycardia. [LIDDI_resource:SID3421_SID0786_EID4970]127
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and linezolid - Event - Bradycardia. [LIDDI_resource:SID3421_SID2978_EID4970]197
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between dasatinib and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID4078_SID3421_EID4970]205
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between citalopram and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID0307_SID3421_EID4963]13
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between heparin and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID0624_SID3421_EID0003]32
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between morphine and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0869_SID3421_EID4971]41
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between omeprazole and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID0936_SID3421_EID4970]45
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between felbamate and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID1761_SID3421_EID4962]60
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between terazosin and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2212_SID3421_EID4962]71
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between fosinopril and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID2422_SID3421_EID4963]80
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between lamivudine and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID2582_SID3421_EID4963]86
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between donepezil and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2905_SID3421_EID4962]95
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and gabapentin - Event - Neutropenia. [LIDDI_resource:SID3421_SID1806_EID4963]157
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and felbamate - Event - Pancytopenia. [LIDDI_resource:SID3421_SID1761_EID4962]155
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and cefuroxime - Event - Bradycardia. [LIDDI_resource:SID3421_SID0253_EID4970]101
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ceftriaxone and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID0252_SID3421_EID4963]10
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between etoposide and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0517_SID3421_EID4971]23
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between fluconazole and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID0545_SID3421_EID4970]26
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between furosemide and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0578_SID3421_EID4962]28
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between lovastatin and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0756_SID3421_EID4962]34
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between scopolamine and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID1184_SID3421_EID4970]53
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ketorolac and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID2149_SID3421_EID0002]69
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between oxybutynin and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2026_SID3421_EID4962]64
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between lisinopril and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID1909_SID3421_EID4962]63
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between topiramate and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2247_SID3421_EID4962]72
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between doxazosin and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2414_SID3421_EID4971]79
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between pravastatin and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID2349_SID3421_EID4970]76
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between tizanidine and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID2503_SID3421_EID4965]83
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between filgrastim and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2583_SID3421_EID4962]87
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and tizanidine - Event - Parkinsonism. [LIDDI_resource:SID3421_SID2503_EID4965]184
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and pravastatin - Event - Bradycardia. [LIDDI_resource:SID3421_SID2349_EID4970]175
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and vinorelbine - Event - Bradycardia. [LIDDI_resource:SID3421_SID2286_EID4970]171
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and mannitol - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID0770_EID0003]126
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and doxazosin - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2414_EID4971]178
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and citalopram - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0307_EID4962]103
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and sevelamer - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID3022_EID4971]198
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and ketorolac - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID2149_EID0002]165
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between fentanyl and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID0535_SID3421_EID4970]25
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ramipril and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID2129_SID3421_EID4970]68
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and losartan - Event - Bradycardia. [LIDDI_resource:SID3421_SID2447_EID4970]182
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and lidocaine - Event - Arrhythmia. [LIDDI_resource:SID3421_SID0742_EID4966]123
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and acarbose - Event - Neutropenia. [LIDDI_resource:SID3421_SID1451_EID4963]149
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between allopurinol and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0054_SID3421_EID4962]2
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between cimetidine and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0302_SID3421_EID4971]12
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between dapsone and valganciclovir - Event - Long QT syndrome. [LIDDI_resource:SID0372_SID3421_EID4959]17
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between clotrimazole and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID0325_SID3421_EID4963]14
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between metolazone and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0846_SID3421_EID4971]40
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between prednisone and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID1092_SID3421_EID0002]48
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between prednisone and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID1092_SID3421_EID4971]50
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between procarbazine and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID1102_SID3421_EID4963]51
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between triamterene and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID1333_SID3421_EID4965]56
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between amlodipine and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID1491_SID3421_EID4971]58
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between tacrolimus and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID2332_SID3421_EID0002]74
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between tacrolimus and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2332_SID3421_EID4971]75
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between tolterodine and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2865_SID3421_EID4962]94
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and famotidine - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID0525_EID0002]114
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and metolazone - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0846_EID4971]131
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and metoprolol - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0847_EID4971]132
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and minoxidil - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID0860_EID0003]134
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and procarbazine - Event - Neutropenia. [LIDDI_resource:SID3421_SID1102_EID4963]143
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and loratadine - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID1903_EID0002]159
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and amlodipine - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID1491_EID4971]151
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and triamterene - Event - Parkinsonism. [LIDDI_resource:SID3421_SID1333_EID4965]145
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2977_EID4971]196
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and clotrimazole - Event - Neutropenia. [LIDDI_resource:SID3421_SID0325_EID4963]106
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and fluconazole - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0545_EID4962]116
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and lovastatin - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID0756_EID0002]124
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and atorvastatin - Event - Neutropenia. [LIDDI_resource:SID3421_SID2682_EID4963]190
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and nesiritide - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID1558_EID0002]152
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and rabeprazole - Event - Pancytopenia. [LIDDI_resource:SID3421_SID2853_EID4962]195
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between heparin and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0624_SID3421_EID4971]33
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between tramadol and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID1324_SID3421_EID4965]54
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between docetaxel and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID2629_SID3421_EID4963]90
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and tramadol - Event - Pancytopenia. [LIDDI_resource:SID3421_SID1324_EID4962]144
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and letrozole - Event - Bradycardia. [LIDDI_resource:SID3421_SID2630_EID4970]187
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and cyclophosphamide - Event - Neutropenia. [LIDDI_resource:SID3421_SID0358_EID4963]109
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between gefitinib and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID3863_SID3421_EID4970]203
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and gefitinib - Event - Bradycardia. [LIDDI_resource:SID3421_SID3863_EID4970]201
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and cefepime - Event - Pancytopenia. [LIDDI_resource:SID3421_SID1603_EID4962]153
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ganciclovir and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID0584_SID3421_EID0002]30
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between glucosamine and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0598_SID3421_EID4971]31
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between methotrexate and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0829_SID3421_EID4962]38
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between omeprazole and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID0936_SID3421_EID0003]44
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between atorvastatin and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2682_SID3421_EID4962]92
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between fexofenadine and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID2704_SID3421_EID4965]93
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and lisinopril - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID1909_EID0003]160
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and hydralazine - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0640_EID4971]122
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and ganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID0584_EID0002]120
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and fludarabine - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID1757_EID0002]154
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between caffeine and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0197_SID3421_EID4971]5
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between calcitriol and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID0199_SID3421_EID4963]6
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between cefazolin and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID0241_SID3421_EID4965]8
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between etomidate and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID0516_SID3421_EID4965]21
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between folic acid and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID0570_SID3421_EID4970]27
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between furosemide and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID0578_SID3421_EID4963]29
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between metformin and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0810_SID3421_EID4962]37
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and cimetidine - Event - Neutropenia. [LIDDI_resource:SID3421_SID0302_EID4963]102
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and folic acid - Event - Bradycardia. [LIDDI_resource:SID3421_SID0570_EID4970]118
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and prednisone - Event - Neutropenia. [LIDDI_resource:SID3421_SID1092_EID4963]142
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and salmeterol - Event - Neutropenia. [LIDDI_resource:SID3421_SID2154_EID4963]166
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and terazosin - Event - Pancytopenia. [LIDDI_resource:SID3421_SID2212_EID4962]169
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and fosinopril - Event - Neutropenia. [LIDDI_resource:SID3421_SID2422_EID4963]179
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and caffeine - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0197_EID4971]99
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and lovastatin - Event - Bradycardia. [LIDDI_resource:SID3421_SID0756_EID4970]125
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and citalopram - Event - Neutropenia. [LIDDI_resource:SID3421_SID0307_EID4963]104
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and omeprazole - Event - Neutropenia. [LIDDI_resource:SID3421_SID0936_EID4963]141
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between acetazolamide and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID0019_SID3421_EID4965]1
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between pegaspargase and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID2084_SID3421_EID0002]66
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between simvastatin and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID2167_SID3421_EID0003]70
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between famciclovir and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID2578_SID3421_EID0003]84
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between palonosetron and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2602_SID3421_EID4971]89
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and lansoprazole - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID1463_EID4971]150
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and rizatriptan - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID2707_EID0003]192
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and pegaspargase - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID2084_EID0002]163
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between etomidate and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID0516_SID3421_EID0002]20
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between fentanyl and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID0535_SID3421_EID0003]24
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between mannitol and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID0770_SID3421_EID0003]35
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ranitidine and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID1155_SID3421_EID4965]52
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between loratadine and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID1903_SID3421_EID4962]62
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between clopidogrel and valganciclovir - Event - Bradycardia. [LIDDI_resource:SID2038_SID3421_EID4970]65
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between lamivudine and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2582_SID3421_EID4962]85
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between pemetrexed and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2584_SID3421_EID4962]88
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and fluconazole - Event - Neutropenia. [LIDDI_resource:SID3421_SID0545_EID4963]117
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and warfarin - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID1397_EID0003]147
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and topiramate - Event - Pancytopenia. [LIDDI_resource:SID3421_SID2247_EID4962]170
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and foscarnet - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID2057_EID0002]162
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and omeprazole - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0936_EID4962]140
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and minoxidil - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID0860_EID0002]133
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and gabapentin - Event - Pancytopenia. [LIDDI_resource:SID3421_SID1806_EID4962]156
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between betamethasone and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID0163_SID3421_EID0002]4
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between bortezomib and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID4002_SID3421_EID4965]204
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and dexamethasone - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0390_EID4971]111
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and cefuroxime - Event - Long QT syndrome. [LIDDI_resource:SID3421_SID0253_EID4959]100
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between ceftriaxone and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0252_SID3421_EID4962]9
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between omeprazole and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0936_SID3421_EID4971]46
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between paclitaxel and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID2497_SID3421_EID0002]82
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between daclizumab and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID3421_EID4971]96
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and furosemide - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0578_EID4971]119
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and tacrolimus - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID2332_EID0002]173
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and paclitaxel - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID2497_EID0002]183
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and rizatriptan - Event - Parkinsonism. [LIDDI_resource:SID3421_SID2707_EID4965]194
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and tacrolimus - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2332_EID4971]174
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between cefazolin and valganciclovir - Event - Serotonin syndrome. [LIDDI_resource:SID0241_SID3421_EID4964]7
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and rizatriptan - Event - Long QT syndrome. [LIDDI_resource:SID3421_SID2707_EID4959]193
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between pentostatin and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID0990_SID3421_EID0002]47
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between prednisone and valganciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID1092_SID3421_EID0003]49
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between fludarabine and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID1757_SID3421_EID0002]59
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between pravastatin and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2349_SID3421_EID4971]77
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and glimepiride - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID1813_EID4971]158
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between pantoprazole and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID2318_SID3421_EID4962]73
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and pravastatin - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2349_EID4971]176
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and atorvastatin - Event - Pancytopenia. [LIDDI_resource:SID3421_SID2682_EID4962]189
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and methotrexate - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0829_EID4962]129
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and fexofenadine - Event - Parkinsonism. [LIDDI_resource:SID3421_SID2704_EID4965]191
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between cyclophosphamide and valganciclovir - Event - Pancytopenia. [LIDDI_resource:SID0358_SID3421_EID4962]15
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and lisinopril - Event - Serotonin syndrome. [LIDDI_resource:SID3421_SID1909_EID4964]161
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and pemetrexed - Event - Serotonin syndrome. [LIDDI_resource:SID3421_SID2584_EID4964]186
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between dofetilide and valganciclovir - Event - Serotonin syndrome. [LIDDI_resource:SID2413_SID3421_EID4964]78
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and quetiapine - Event - Serotonin syndrome. [LIDDI_resource:SID3421_SID2431_EID4964]180
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and insulin glargine - Event - Parkinsonism. [LIDDI_resource:SID3421_SID3417_EID4965]199
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between lansoprazole and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID1463_SID3421_EID4971]57
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and famciclovir - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID2578_EID0003]185
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and clomipramine - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0316_EID4971]105
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and pantoprazole - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2318_EID4971]172
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and estradiol - Event - Long QT syndrome. [LIDDI_resource:SID3421_SID0491_EID4959]112
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and paricalcitol - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID2642_EID0002]188
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between esomeprazole and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID3471_SID3421_EID4971]202
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and simvastatin - Event - Rhabdomyolysis. [LIDDI_resource:SID3421_SID2167_EID0003]167
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and mycophenolic acid - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0874_EID4962]136
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and insulin glargine - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID3417_EID4971]200
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and sodium bicarbonate - Event - Neutropenia. [LIDDI_resource:SID3421_SID2170_EID4963]168
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between dexamethasone and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0390_SID3421_EID4971]18
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and colchicine - Event - Long QT syndrome. [LIDDI_resource:SID3421_SID0333_EID4959]107
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and irinotecan - Event - Long QT syndrome. [LIDDI_resource:SID3421_SID2438_EID4959]181
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and nifedipine - Event - Long QT syndrome. [LIDDI_resource:SID3421_SID0901_EID4959]139
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and betamethasone - Event - Hypoglycaemia. [LIDDI_resource:SID3421_SID0163_EID0002]98
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between azacitidine and valganciclovir - Event - Long QT syndrome. [LIDDI_resource:SID0127_SID3421_EID4959]3
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between cyclophosphamide and valganciclovir - Event - Neutropenia. [LIDDI_resource:SID0358_SID3421_EID4963]16
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between melphalan and valganciclovir - Event - Serotonin syndrome. [LIDDI_resource:SID0789_SID3421_EID4964]36
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between nitrofurantoin and valganciclovir - Event - Hypoglycaemia. [LIDDI_resource:SID0912_SID3421_EID0002]42
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and melphalan - Event - Serotonin syndrome. [LIDDI_resource:SID3421_SID0789_EID4964]128
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between triamcinolone and valganciclovir - Event - Serotonin syndrome. [LIDDI_resource:SID1332_SID3421_EID4964]55
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and methylprednisolone - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID0841_EID4971]130
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between quetiapine and valganciclovir - Event - Serotonin syndrome. [LIDDI_resource:SID2431_SID3421_EID4964]81
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and mycophenolic acid - Event - Neutropenia. [LIDDI_resource:SID3421_SID0874_EID4963]137
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and cyclophosphamide - Event - Pancytopenia. [LIDDI_resource:SID3421_SID0358_EID4962]108
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between insulin glargine and valganciclovir - Event - Parkinsonism. [LIDDI_resource:SID3417_SID3421_EID4965]97
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and dofetilide - Event - Serotonin syndrome. [LIDDI_resource:SID3421_SID2413_EID4964]177
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between valganciclovir and gemfibrozil - Event - Serotonin syndrome. [LIDDI_resource:SID3421_SID0587_EID4964]121
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between itraconazole and valganciclovir - Event - Serotonin syndrome. [LIDDI_resource:SID1877_SID3421_EID4964]61
dv:drugbank_vocabulary:ddi-interactor-in
ddir:DDI between methylprednisolone and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID0841_SID3421_EID4971]39

Named graphs describing this resource:

1http://liddi.stanford.edu/LIDDI_resource:SID0019_SID3421_EID4965_nanopubassertion
2http://liddi.stanford.edu/LIDDI_resource:SID0054_SID3421_EID4962_nanopubassertion
3http://liddi.stanford.edu/LIDDI_resource:SID0127_SID3421_EID4959_nanopubassertion
4http://liddi.stanford.edu/LIDDI_resource:SID0163_SID3421_EID0002_nanopubassertion
5http://liddi.stanford.edu/LIDDI_resource:SID0197_SID3421_EID4971_nanopubassertion
6http://liddi.stanford.edu/LIDDI_resource:SID0199_SID3421_EID4963_nanopubassertion
7http://liddi.stanford.edu/LIDDI_resource:SID0241_SID3421_EID4964_nanopubassertion
8http://liddi.stanford.edu/LIDDI_resource:SID0241_SID3421_EID4965_nanopubassertion
9http://liddi.stanford.edu/LIDDI_resource:SID0252_SID3421_EID4962_nanopubassertion
10http://liddi.stanford.edu/LIDDI_resource:SID0252_SID3421_EID4963_nanopubassertion
11http://liddi.stanford.edu/LIDDI_resource:SID0253_SID3421_EID4966_nanopubassertion
12http://liddi.stanford.edu/LIDDI_resource:SID0302_SID3421_EID4971_nanopubassertion
13http://liddi.stanford.edu/LIDDI_resource:SID0307_SID3421_EID4963_nanopubassertion
14http://liddi.stanford.edu/LIDDI_resource:SID0325_SID3421_EID4963_nanopubassertion
15http://liddi.stanford.edu/LIDDI_resource:SID0358_SID3421_EID4962_nanopubassertion
16http://liddi.stanford.edu/LIDDI_resource:SID0358_SID3421_EID4963_nanopubassertion
17http://liddi.stanford.edu/LIDDI_resource:SID0372_SID3421_EID4959_nanopubassertion
18http://liddi.stanford.edu/LIDDI_resource:SID0390_SID3421_EID4971_nanopubassertion
19http://liddi.stanford.edu/LIDDI_resource:SID0491_SID3421_EID4966_nanopubassertion
20http://liddi.stanford.edu/LIDDI_resource:SID0516_SID3421_EID0002_nanopubassertion
21http://liddi.stanford.edu/LIDDI_resource:SID0516_SID3421_EID4965_nanopubassertion
22http://liddi.stanford.edu/LIDDI_resource:SID0516_SID3421_EID4970_nanopubassertion
23http://liddi.stanford.edu/LIDDI_resource:SID0517_SID3421_EID4971_nanopubassertion
24http://liddi.stanford.edu/LIDDI_resource:SID0535_SID3421_EID0003_nanopubassertion
25http://liddi.stanford.edu/LIDDI_resource:SID0535_SID3421_EID4970_nanopubassertion
26http://liddi.stanford.edu/LIDDI_resource:SID0545_SID3421_EID4970_nanopubassertion
27http://liddi.stanford.edu/LIDDI_resource:SID0570_SID3421_EID4970_nanopubassertion
28http://liddi.stanford.edu/LIDDI_resource:SID0578_SID3421_EID4962_nanopubassertion
29http://liddi.stanford.edu/LIDDI_resource:SID0578_SID3421_EID4963_nanopubassertion
30http://liddi.stanford.edu/LIDDI_resource:SID0584_SID3421_EID0002_nanopubassertion
31http://liddi.stanford.edu/LIDDI_resource:SID0598_SID3421_EID4971_nanopubassertion
32http://liddi.stanford.edu/LIDDI_resource:SID0624_SID3421_EID0003_nanopubassertion
33http://liddi.stanford.edu/LIDDI_resource:SID0624_SID3421_EID4971_nanopubassertion
34http://liddi.stanford.edu/LIDDI_resource:SID0756_SID3421_EID4962_nanopubassertion
35http://liddi.stanford.edu/LIDDI_resource:SID0770_SID3421_EID0003_nanopubassertion
36http://liddi.stanford.edu/LIDDI_resource:SID0789_SID3421_EID4964_nanopubassertion
37http://liddi.stanford.edu/LIDDI_resource:SID0810_SID3421_EID4962_nanopubassertion
38http://liddi.stanford.edu/LIDDI_resource:SID0829_SID3421_EID4962_nanopubassertion
39http://liddi.stanford.edu/LIDDI_resource:SID0841_SID3421_EID4971_nanopubassertion
40http://liddi.stanford.edu/LIDDI_resource:SID0846_SID3421_EID4971_nanopubassertion
41http://liddi.stanford.edu/LIDDI_resource:SID0869_SID3421_EID4971_nanopubassertion
42http://liddi.stanford.edu/LIDDI_resource:SID0912_SID3421_EID0002_nanopubassertion
43http://liddi.stanford.edu/LIDDI_resource:SID0930_SID3421_EID4970_nanopubassertion
44http://liddi.stanford.edu/LIDDI_resource:SID0936_SID3421_EID0003_nanopubassertion
45http://liddi.stanford.edu/LIDDI_resource:SID0936_SID3421_EID4970_nanopubassertion
46http://liddi.stanford.edu/LIDDI_resource:SID0936_SID3421_EID4971_nanopubassertion
47http://liddi.stanford.edu/LIDDI_resource:SID0990_SID3421_EID0002_nanopubassertion
48http://liddi.stanford.edu/LIDDI_resource:SID1092_SID3421_EID0002_nanopubassertion
49http://liddi.stanford.edu/LIDDI_resource:SID1092_SID3421_EID0003_nanopubassertion
50http://liddi.stanford.edu/LIDDI_resource:SID1092_SID3421_EID4971_nanopubassertion
51http://liddi.stanford.edu/LIDDI_resource:SID1102_SID3421_EID4963_nanopubassertion
52http://liddi.stanford.edu/LIDDI_resource:SID1155_SID3421_EID4965_nanopubassertion
53http://liddi.stanford.edu/LIDDI_resource:SID1184_SID3421_EID4970_nanopubassertion
54http://liddi.stanford.edu/LIDDI_resource:SID1324_SID3421_EID4965_nanopubassertion
55http://liddi.stanford.edu/LIDDI_resource:SID1332_SID3421_EID4964_nanopubassertion
56http://liddi.stanford.edu/LIDDI_resource:SID1333_SID3421_EID4965_nanopubassertion
57http://liddi.stanford.edu/LIDDI_resource:SID1463_SID3421_EID4971_nanopubassertion
58http://liddi.stanford.edu/LIDDI_resource:SID1491_SID3421_EID4971_nanopubassertion
59http://liddi.stanford.edu/LIDDI_resource:SID1757_SID3421_EID0002_nanopubassertion
60http://liddi.stanford.edu/LIDDI_resource:SID1761_SID3421_EID4962_nanopubassertion
61http://liddi.stanford.edu/LIDDI_resource:SID1877_SID3421_EID4964_nanopubassertion
62http://liddi.stanford.edu/LIDDI_resource:SID1903_SID3421_EID4962_nanopubassertion
63http://liddi.stanford.edu/LIDDI_resource:SID1909_SID3421_EID4962_nanopubassertion
64http://liddi.stanford.edu/LIDDI_resource:SID2026_SID3421_EID4962_nanopubassertion
65http://liddi.stanford.edu/LIDDI_resource:SID2038_SID3421_EID4970_nanopubassertion
66http://liddi.stanford.edu/LIDDI_resource:SID2084_SID3421_EID0002_nanopubassertion
67http://liddi.stanford.edu/LIDDI_resource:SID2129_SID3421_EID4965_nanopubassertion
68http://liddi.stanford.edu/LIDDI_resource:SID2129_SID3421_EID4970_nanopubassertion
69http://liddi.stanford.edu/LIDDI_resource:SID2149_SID3421_EID0002_nanopubassertion
70http://liddi.stanford.edu/LIDDI_resource:SID2167_SID3421_EID0003_nanopubassertion
71http://liddi.stanford.edu/LIDDI_resource:SID2212_SID3421_EID4962_nanopubassertion
72http://liddi.stanford.edu/LIDDI_resource:SID2247_SID3421_EID4962_nanopubassertion
73http://liddi.stanford.edu/LIDDI_resource:SID2318_SID3421_EID4962_nanopubassertion
74http://liddi.stanford.edu/LIDDI_resource:SID2332_SID3421_EID0002_nanopubassertion
75http://liddi.stanford.edu/LIDDI_resource:SID2332_SID3421_EID4971_nanopubassertion
76http://liddi.stanford.edu/LIDDI_resource:SID2349_SID3421_EID4970_nanopubassertion
77http://liddi.stanford.edu/LIDDI_resource:SID2349_SID3421_EID4971_nanopubassertion
78http://liddi.stanford.edu/LIDDI_resource:SID2413_SID3421_EID4964_nanopubassertion
79http://liddi.stanford.edu/LIDDI_resource:SID2414_SID3421_EID4971_nanopubassertion
80http://liddi.stanford.edu/LIDDI_resource:SID2422_SID3421_EID4963_nanopubassertion
81http://liddi.stanford.edu/LIDDI_resource:SID2431_SID3421_EID4964_nanopubassertion
82http://liddi.stanford.edu/LIDDI_resource:SID2497_SID3421_EID0002_nanopubassertion
83http://liddi.stanford.edu/LIDDI_resource:SID2503_SID3421_EID4965_nanopubassertion
84http://liddi.stanford.edu/LIDDI_resource:SID2578_SID3421_EID0003_nanopubassertion
85http://liddi.stanford.edu/LIDDI_resource:SID2582_SID3421_EID4962_nanopubassertion
86http://liddi.stanford.edu/LIDDI_resource:SID2582_SID3421_EID4963_nanopubassertion
87http://liddi.stanford.edu/LIDDI_resource:SID2583_SID3421_EID4962_nanopubassertion
88http://liddi.stanford.edu/LIDDI_resource:SID2584_SID3421_EID4962_nanopubassertion
89http://liddi.stanford.edu/LIDDI_resource:SID2602_SID3421_EID4971_nanopubassertion
90http://liddi.stanford.edu/LIDDI_resource:SID2629_SID3421_EID4963_nanopubassertion
91http://liddi.stanford.edu/LIDDI_resource:SID2630_SID3421_EID4970_nanopubassertion
92http://liddi.stanford.edu/LIDDI_resource:SID2682_SID3421_EID4962_nanopubassertion
93http://liddi.stanford.edu/LIDDI_resource:SID2704_SID3421_EID4965_nanopubassertion
94http://liddi.stanford.edu/LIDDI_resource:SID2865_SID3421_EID4962_nanopubassertion
95http://liddi.stanford.edu/LIDDI_resource:SID2905_SID3421_EID4962_nanopubassertion
96http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3421_EID4971_nanopubassertion
97http://liddi.stanford.edu/LIDDI_resource:SID3417_SID3421_EID4965_nanopubassertion
98http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0163_EID0002_nanopubassertion
99http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0197_EID4971_nanopubassertion
100http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0253_EID4959_nanopubassertion
101http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0253_EID4970_nanopubassertion
102http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0302_EID4963_nanopubassertion
103http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0307_EID4962_nanopubassertion
104http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0307_EID4963_nanopubassertion
105http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0316_EID4971_nanopubassertion
106http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0325_EID4963_nanopubassertion
107http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0333_EID4959_nanopubassertion
108http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0358_EID4962_nanopubassertion
109http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0358_EID4963_nanopubassertion
110http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0372_EID4963_nanopubassertion
111http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0390_EID4971_nanopubassertion
112http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0491_EID4959_nanopubassertion
113http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0516_EID4966_nanopubassertion
114http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0525_EID0002_nanopubassertion
115http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0542_EID4966_nanopubassertion
116http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0545_EID4962_nanopubassertion
117http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0545_EID4963_nanopubassertion
118http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0570_EID4970_nanopubassertion
119http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0578_EID4971_nanopubassertion
120http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0584_EID0002_nanopubassertion
121http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0587_EID4964_nanopubassertion
122http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0640_EID4971_nanopubassertion
123http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0742_EID4966_nanopubassertion
124http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0756_EID0002_nanopubassertion
125http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0756_EID4970_nanopubassertion
126http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0770_EID0003_nanopubassertion
127http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0786_EID4970_nanopubassertion
128http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0789_EID4964_nanopubassertion
129http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0829_EID4962_nanopubassertion
130http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0841_EID4971_nanopubassertion
131http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0846_EID4971_nanopubassertion
132http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0847_EID4971_nanopubassertion
133http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0860_EID0002_nanopubassertion
134http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0860_EID0003_nanopubassertion
135http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0869_EID4971_nanopubassertion
136http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0874_EID4962_nanopubassertion
137http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0874_EID4963_nanopubassertion
138http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0886_EID4962_nanopubassertion
139http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0901_EID4959_nanopubassertion
140http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0936_EID4962_nanopubassertion
141http://liddi.stanford.edu/LIDDI_resource:SID3421_SID0936_EID4963_nanopubassertion
142http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1092_EID4963_nanopubassertion
143http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1102_EID4963_nanopubassertion
144http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1324_EID4962_nanopubassertion
145http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1333_EID4965_nanopubassertion
146http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1388_EID4962_nanopubassertion
147http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1397_EID0003_nanopubassertion
148http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1397_EID4965_nanopubassertion
149http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1451_EID4963_nanopubassertion
150http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1463_EID4971_nanopubassertion
151http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1491_EID4971_nanopubassertion
152http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1558_EID0002_nanopubassertion
153http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1603_EID4962_nanopubassertion
154http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1757_EID0002_nanopubassertion
155http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1761_EID4962_nanopubassertion
156http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1806_EID4962_nanopubassertion
157http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1806_EID4963_nanopubassertion
158http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1813_EID4971_nanopubassertion
159http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1903_EID0002_nanopubassertion
160http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1909_EID0003_nanopubassertion
161http://liddi.stanford.edu/LIDDI_resource:SID3421_SID1909_EID4964_nanopubassertion
162http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2057_EID0002_nanopubassertion
163http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2084_EID0002_nanopubassertion
164http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2129_EID4962_nanopubassertion
165http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2149_EID0002_nanopubassertion
166http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2154_EID4963_nanopubassertion
167http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2167_EID0003_nanopubassertion
168http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2170_EID4963_nanopubassertion
169http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2212_EID4962_nanopubassertion
170http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2247_EID4962_nanopubassertion
171http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2286_EID4970_nanopubassertion
172http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2318_EID4971_nanopubassertion
173http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2332_EID0002_nanopubassertion
174http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2332_EID4971_nanopubassertion
175http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2349_EID4970_nanopubassertion
176http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2349_EID4971_nanopubassertion
177http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2413_EID4964_nanopubassertion
178http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2414_EID4971_nanopubassertion
179http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2422_EID4963_nanopubassertion
180http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2431_EID4964_nanopubassertion
181http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2438_EID4959_nanopubassertion
182http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2447_EID4970_nanopubassertion
183http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2497_EID0002_nanopubassertion
184http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2503_EID4965_nanopubassertion
185http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2578_EID0003_nanopubassertion
186http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2584_EID4964_nanopubassertion
187http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2630_EID4970_nanopubassertion
188http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2642_EID0002_nanopubassertion
189http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2682_EID4962_nanopubassertion
190http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2682_EID4963_nanopubassertion
191http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2704_EID4965_nanopubassertion
192http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2707_EID0003_nanopubassertion
193http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2707_EID4959_nanopubassertion
194http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2707_EID4965_nanopubassertion
195http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2853_EID4962_nanopubassertion
196http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2977_EID4971_nanopubassertion
197http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2978_EID4970_nanopubassertion
198http://liddi.stanford.edu/LIDDI_resource:SID3421_SID3022_EID4971_nanopubassertion
199http://liddi.stanford.edu/LIDDI_resource:SID3421_SID3417_EID4965_nanopubassertion
200http://liddi.stanford.edu/LIDDI_resource:SID3421_SID3417_EID4971_nanopubassertion
201http://liddi.stanford.edu/LIDDI_resource:SID3421_SID3863_EID4970_nanopubassertion
202http://liddi.stanford.edu/LIDDI_resource:SID3471_SID3421_EID4971_nanopubassertion
203http://liddi.stanford.edu/LIDDI_resource:SID3863_SID3421_EID4970_nanopubassertion
204http://liddi.stanford.edu/LIDDI_resource:SID4002_SID3421_EID4965_nanopubassertion
205http://liddi.stanford.edu/LIDDI_resource:SID4078_SID3421_EID4970_nanopubassertion

The resource does not appear as an object

Context graph